Moleculin Biotech, Inc. MBRX
Regular-session close
After hours · Nov 13, 4:00 PM ET
- YTD
- +137.76%
- 1 year
- -30.66%
Discussion (205)
Sign in to join the discussion
Boring boring boring
Good for them for contracting out and outside the early grasp of the FDA by going overseas -a kind of warp speed for treatment which would am sure meets political resistance to slow it down
Hold til EOY 21, will be > 20$
Leveraging their way into greatness
Demented old Biden not curing anything but the slow leak in his bank account
Dont forget the PT is 21$ (Zacks)
Very excited about price Target of zacks: 21$!!! Lets go!!!
Current sp is so far below liquid assets it’s not funny which is to say it ignores any of the game plan and implies Mgmt squanders all the cash without any success! What a suppression.
Calm before storm. I’ve seen this pattern in other biotech
Based on current valuation, one would be lead to believe it is worth its cash on hand and no more and is expected to deplete it without result. Even if that’s reality, it should have mkt cap of at least 2x cash now in speculation which shows the extent of the game being played.
